Ashfield Market Access' own Steve Stefano was quoted in author Jaimy Lee’s article on the State of the Union on drug pricing appearing in the February 2016 issue of MM&M (Medical Marketing & Media).
The article titled “The Payer Strikes Back” discusses how Express Scripts’ Steve Miller is taking on the industry in a drug pricing battle.
For drugmakers, the anticipated prevalence of formulary exclusions will present new challenges in bringing a drug to market. The likely casualty? Traditional marketing models. Steve Stefano, CEO of Ashfield Market Access, says that pharma companies must insist on engaging with PBMs at senior levels. “This is the biggest impact on P&L that there is,” he notes. “If they’re not doing this, they’re not doing their job.”